Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.16B |
| 2 |
Uber
UBER
|
+$452M |
| 3 |
Analog Devices
ADI
|
+$421M |
| 4 |
Walt Disney
DIS
|
+$376M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$375M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.55B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.08B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$430M |
| 4 |
NVIDIA
NVDA
|
+$368M |
| 5 |
JPMorgan Chase
JPM
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.78% |
| 2 | Healthcare | 3.27% |
| 3 | Industrials | 2.02% |
| 4 | Financials | 2.02% |
| 5 | Consumer Discretionary | 1.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GFX.U
2051
DELISTED
Golden Falcon Acquisition Corp. Units, each consisting of one share of Class A Common Stock and one-half of one Warrant
GFX.U
| $14.7M | ﹤0.01% |
+1,408,883
| New | +$14.6M |
|
2052
Aflac
AFL
$60.9B
| $14.6M | ﹤0.01% |
329,357
-3,025,681
| -90% | -$124M |
|
2053
Tenaris
TS
$27B
| $14.6M | ﹤0.01% |
918,302
+768,764
| +514% | +$10.2M |
|
2054
DraftKings
DKNG
$13B
| $14.6M | ﹤0.01% |
314,296
-258,258
| -45% | -$12.3M |
|
2055
PUT
Parker-Hannifin
PH
$133B
| $14.6M | ﹤0.01% |
53,600
+9,900
| +23% | +$2.45M |
|
2056
CALL
Yelp
YELP
$1.34B
| $14.6M | ﹤0.01% |
446,400
+212,400
| +91% | +$5.58M |
|
2057
CALL
Cummins
CMI
$86.9B
| $14.6M | ﹤0.01% |
64,200
-76,300
| -54% | -$17.1M |
|
2058
PUT
Novartis
NVS
$287B
| $14.6M | ﹤0.01% |
154,100
+37,000
| +32% | +$3.23M |
|
2059
iShares Semiconductor ETF
SOXX
$46.5B
| $14.6M | ﹤0.01% |
115,125
-4,944
| -4% | -$568K |
|
2060
PUT
Newell Brands
NWL
$2.66B
| $14.5M | ﹤0.01% |
685,100
-84,200
| -11% | -$1.64M |
|
2061
iShares MSCI World ETF
URTH
$8.39B
| $14.5M | ﹤0.01% |
129,278
-41,936
| -24% | -$4.45M |
|
2062
CALL
Nutrien
NTR
$32.6B
| $14.5M | ﹤0.01% |
301,300
-25,800
| -8% | -$1.14M |
|
2063
Energy Transfer Partners
ET
$72.5B
| $14.5M | ﹤0.01% |
2,347,828
+1,554,644
| +196% | +$9.41M |
|
2064
CALL
DaVita
DVA
$11.5B
| $14.5M | ﹤0.01% |
123,400
+17,100
| +16% | +$1.74M |
|
|
CBAY
2065
DELISTED
Cymabay Therapeutics
CBAY
| $14.5M | ﹤0.01% |
2,523,425
+301,870
| +14% | +$2.29M |
|
2066
Icon
ICLR
$12.6B
| $14.4M | ﹤0.01% |
74,073
+66,235
| +845% | +$13M |
|
2067
Hancock Whitney
HWC
$6.4B
| $14.4M | ﹤0.01% |
423,460
+158,738
| +60% | +$4.28M |
|
2068
United States Natural Gas Fund
UNG
$487M
| $14.4M | ﹤0.01% |
391,336
+199,667
| +104% | +$8.61M |
|
|
NKLA
2069
CALL
DELISTED
Nikola Corporation Common Stock
NKLA
| $14.4M | ﹤0.01% |
31,433
-7,294
| -19% | -$4.54M |
|
2070
CALL
Thor Industries
THO
$4.11B
| $14.4M | ﹤0.01% |
154,700
+62,900
| +69% | +$5.9M |
|
2071
CALL
Pool Corp
POOL
$7.08B
| $14.4M | ﹤0.01% |
38,600
+13,700
| +55% | +$4.78M |
|
|
VCVCU
2072
DELISTED
10X Capital Venture Acquisition Corp Unit
VCVCU
| $14.4M | ﹤0.01% |
+1,350,000
| New | +$13.9M |
|
2073
Cogent Communications
CCOI
$579M
| $14.4M | ﹤0.01% |
240,020
+63,266
| +36% | +$3.74M |
|
2074
Four Corners Property Trust
FCPT
$2.77B
| $14.3M | ﹤0.01% |
480,729
-32,797
| -6% | -$919K |
|
2075
CALL
Asana
ASAN
$2.11B
| $14.3M | ﹤0.01% |
+484,000
| New | +$12.4M |
|
Similar funds
Ken Griffin's Q4 2020 Portfolio in Review
As of Q4 2020, Ken Griffin held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.8% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Ken Griffin opened a new position in S&P Global worth $114M.
- Ken Griffin's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
- Ken Griffin added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
- Ken Griffin's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
- Ken Griffin fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
- Ken Griffin's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
- Ken Griffin opened 1,988 new positions and closed 1,130 in Q4 2020.
- Ken Griffin's portfolio value rose 9.1% quarter-over-quarter to $385B.
Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.